Circulating tumor DNA fraction correlates with residual cancer burden postneoadjuvant chemotherapy in triple negative breast cancer patients

被引：0
|
作者：
Shan, Naing Lin
Gould, Billie
Blenman, Kim
Foldi, Julia
Du, Pan
Zhang, Frank
Walsh, Myles
Pusztai, Lajos
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-14-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-14-05
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer
    Shang, Mao
    Chang, Chunxiao
    Pei, Yanqing
    Guan, Yin
    Chang, Jin
    Li, HuiHui
    JOURNAL OF CANCER, 2018, 9 (24): : 4627 - 4634
  • [42] Circulating Tumor DNA as a Novel Biomarker Optimizing Treatment for Triple Negative Breast Cancer
    Sun, Yue
    Zhu, Chengjun
    Xu, Feng
    Cui, Shiyun
    Guan, Xiaoxiang
    CLINICAL BREAST CANCER, 2023, 23 (04) : 339 - 349
  • [43] Circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)
    Lucci, A.
    Hall, C.
    Hess, K.
    Ravenberg, E.
    Clayborn, A.
    Mittendorf, E.
    Rauch, G.
    Candelaria, R.
    Moulder, S.
    Thompson, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [44] Residual Cancer Burden After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Elder, E. A.
    Livasy, C.
    Donahue, E.
    Neelands, B. J.
    Patrick, A.
    Needham, M.
    Sarantou, T.
    Hadzikadic-Gusic, L.
    White, R.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S53 - S53
  • [45] Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer
    Sheppard, Vanessa B.
    Cavalli, Luciane R.
    Dash, Chiranjeev
    Kanaan, Yasmine M.
    Dilawari, Asma A.
    Horton, Sara
    Makambi, Kepher H.
    CLINICAL BREAST CANCER, 2017, 17 (03) : 232 - 238
  • [46] Peripheral immune subsets and circulating tumor DNA (ctDNA) in patients (pts) with residual triple negative breast cancer (TNBC) treated with adjuvant immunotherapy and/or chemotherapy (chemo): The OXEL study
    Lynce, Filipa
    Mainor, Candace
    Geng, Xue
    Jones, Greg
    Schlam, Ilana
    Wang, Hongkun
    Feger, Ute
    Donahue, Renee
    Toney, Nicole
    Jochems, Caroline
    Schlom, Jeffrey
    Gallagher, Christopher
    Nanda, Rita
    Graham, Deena
    Stringer-Reasor, Erica M.
    Denduluri, Neelima
    Collins, Julie
    Dilawari, Asma A.
    Chitalia, Ami
    Tiwari, Shruti
    Nunes, Raquel
    Kaltman, Rebecca
    Khoury, Katia
    Gatti-Mays, Margaret
    Swain, Sandra M.
    Parsons, Heather A.
    Pohlmann, Paula
    Isaacs, Claudine
    CANCER RESEARCH, 2022, 82 (04)
  • [47] Circulating tumor DNA (ctDNA) predicts prognosis in triple-negative breast cancer patients: A systematic review
    Lokanata, Edellin F.
    Frandi, Beatrix L.
    Wijaya, Jeremiah H.
    Purnomo, Alexander E.
    Tumiwa, Gabriella H.
    Lokanata, Michael G.
    Heriyanto, Rivaldo S.
    Kurniawan, Andree
    ANNALS OF ONCOLOGY, 2023, 34 : S1422 - S1423
  • [48] Use of Circulating Tumor DNA (ctDNA) for Early Molecular Detection of Breast Cancer Relapse in Patients with Triple-Negative Breast Cancer (TNBC)
    Nusayba A. Bagegni
    Foluso O. Ademuyiwa
    Current Breast Cancer Reports, 2023, 15 : 356 - 363
  • [49] Use of Circulating Tumor DNA (ctDNA) for Early Molecular Detection of Breast Cancer Relapse in Patients with Triple-Negative Breast Cancer (TNBC)
    Bagegni, Nusayba A.
    Ademuyiwa, Foluso O.
    CURRENT BREAST CANCER REPORTS, 2023, 15 (04) : 356 - 363
  • [50] Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy
    Oner, Gizem
    Onder, Semen
    Karatay, Huseyin
    Ak, Naziye
    Tukenmez, Mustafa
    Muslumanoglu, Mahmut
    Igci, Abdullah
    Dinccag, Ahmet
    Ozmen, Vahit
    Aydiner, Adnan
    Yavuz, Ekrem
    Cabioglu, Neslihan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
12345